0000093314-14-000001.txt : 20140925
0000093314-14-000001.hdr.sgml : 20140925
20140925155516
ACCESSION NUMBER: 0000093314-14-000001
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20140925
DATE AS OF CHANGE: 20140925
EFFECTIVENESS DATE: 20140925
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: VOLITIONRX LTD
CENTRAL INDEX KEY: 0000093314
STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
IRS NUMBER: 911949078
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-225327
FILM NUMBER: 141120673
BUSINESS ADDRESS:
STREET 1: 150 ORCHARD ROAD
CITY: ORCHARD PLAZA 08-02
STATE: U0
ZIP: 238841
BUSINESS PHONE: 000-000-0000
MAIL ADDRESS:
STREET 1: 150 ORCHARD ROAD
CITY: ORCHARD PLAZA 08-02
STATE: U0
ZIP: 238841
FORMER COMPANY:
FORMER CONFORMED NAME: STANDARD CAPITAL CORP
DATE OF NAME CHANGE: 19990812
D
1
primary_doc.xml
X0707
D
LIVE
0000093314
VOLITIONRX LTD
1 Scotts Road
#24-05 Shaw Centre
Singapore
U0
SINGAPORE
228208
212-618-1750
DELAWARE
STANDARD CAPITAL CORP
Corporation
true
Cameron
Reynolds
1 Scotts Road
#24-05 Shaw Centre
Singapore
U0
SINGAPORE
228208
Executive Officer
Director
President, Chief Executive Officer & Director
Mike
O'Connell
1 Scotts Road
#24-05 Shaw Centre
Singapore
U0
SINGAPORE
228208
Executive Officer
Chief Financial Officer & Treasurer
Rodney
Gerard
Rootsaert
1 Scotts Road
#24-05 Shaw Centre
Singapore
U0
SINGAPORE
228208
Executive Officer
Secretary
Martin
Faulkes
1 Scotts Road
#24-05 Shaw Centre
Singapore
U0
SINGAPORE
228208
Director
Guy
Archibold
Innes
1 Scotts Road
#24-05 Shaw Centre
Singapore
U0
SINGAPORE
228208
Director
Alan
Colman
1 Scotts Road
#24-05 Shaw Centre
Singapore
U0
SINGAPORE
228208
Director
Habib
Skaff
1 Scotts Road
#24-05 Shaw Centre
Singapore
U0
SINGAPORE
228208
Director
Biotechnology
Decline to Disclose
- 06b
false
2014-09-24
false
true
false
0
Founding Asset Management ("FAM")
122282
None
None
Vicarage House
58-60 Kensington Church Street
London
X0
UNITED KINGDOM
W8 4DB
NH
NEW HAMPSHIRE
false
1189749
1189749
0
false
7
59906
0
The $59,906 commission was calculated as 7% of the total investment from those certain investors introduced by FAM. Pursuant to a Settlement Agreement, the commission owed was converted into 27,230 shares of common stock.
0
false
VOLITIONRX LTD
Cameron Reynolds
Cameron Reynolds
President, Chief Executive Officer & Director
2014-09-25